<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595201</url>
  </required_header>
  <id_info>
    <org_study_id>SCMM-RND-111</org_study_id>
    <nct_id>NCT04595201</nct_id>
  </id_info>
  <brief_title>Clinical Follow-up of Pregnant Subjects Undergoing NIPT</brief_title>
  <official_title>Clinical Follow-up of Pregnant Subjects Undergoing NIPT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sequenom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Integrated Genetics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sequenom, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To obtain pregnancy outcome data from patients screened for fetal genetic status using&#xD;
      non-invasive pregnancy testing (NIPT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To obtain pregnancy outcome data from patients screened for fetal genetic status using&#xD;
      non-invasive pregnancy testing (NIPT) to analyze the performance of routine assay&#xD;
      enhancements and to identify characteristics associated with adverse obstetric outcome.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 13, 2020</start_date>
  <completion_date type="Anticipated">October 13, 2025</completion_date>
  <primary_completion_date type="Anticipated">October 13, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NIPT clinical outcome performance</measure>
    <time_frame>9 months</time_frame>
    <description>Sensitivity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NIPT clinical outcome performance</measure>
    <time_frame>9 months</time_frame>
    <description>Specificity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NIPT clinical outcome performance</measure>
    <time_frame>9 months</time_frame>
    <description>Positive predictive value</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NIPT clinical outcome performance</measure>
    <time_frame>9 months</time_frame>
    <description>Negative predictive value</description>
  </primary_outcome>
  <enrollment type="Anticipated">25000</enrollment>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIPT</intervention_name>
    <description>Non-invasive pregnancy testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The Study Population will consist of women 18 years of age and older who underwent testing&#xD;
        with a Sequenom NIPT and whose pregnancies should have outcome based upon gestational age&#xD;
        at the time of testing.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject was pregnant and received NIPT from Sequenom/Integrated Genetics&#xD;
&#xD;
          -  Subject was 18 years of age or older at the time of NIPT&#xD;
&#xD;
          -  Pregnancy outcome is available&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Follow-up of pregnant subjects who have undergone NIPT</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kimberly Fanelli, MS, CGC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Integrated Genetics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Fanelli, MS, CGC</last_name>
    <phone>603-714-5063</phone>
    <email>kimberly.fanelli@integratedgenetics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Integrated Genetics</name>
      <address>
        <city>Westborough</city>
        <state>Massachusetts</state>
        <zip>01581</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Fanelli, MS, CGC</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

